(MedPage Today) — SAN FRANCISCO — Patients with colon cancer and comorbid obesity treated with GLP-1 receptor agonists had lower mortality and fewer serious non-cancer complications, a propensity-matched cohort study showed.
The retrospective…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.












